Finance entity
All 1 tracked stories fall under one category: earnings. Adam Schechter is most often covered alongside Biopharma Laboratory Services, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline.
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Adam Schechter is most often covered alongside Biopharma Laboratory Services, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. Adam Schechter appears in 1 tracked Finance story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 174 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Adam Schechter. Shared-story counts are live from our verified record — not editorial picks.
Labcorp Holdings Inc. reported a 5.6% revenue increase to $3.5 billion in Q4 2025, driven by robust diagnostics volume and significant margin expansion. While the company achieved an 18% jump in adjusted EPS, performance was split between a surging Central Laboratory segment and a double-digit decline in Early Development services.
Adam Schechter is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
